[
  {
    "ts": "2026-01-27T12:09:30+00:00",
    "headline": "What Analysts Think Is Reframing Zimmer Biomet (ZBH) Story For Investors",
    "summary": "Zimmer Biomet Holdings is back in focus after a recent reset in its price target, putting fresh attention on how investors are framing the stock right now. With the new target reflecting updated expectations and risks, the story around the company is shifting in ways that matter for anyone tracking the shares. Stay tuned to see how you can keep on top of future changes in this narrative as they unfold. Analyst Price Targets don't always capture the full story. Head over to our Company Report...",
    "url": "https://finance.yahoo.com/news/analysts-think-reframing-zimmer-biomet-120930227.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "faa27509-17b8-37a5-944f-59845a6bac15",
      "content": {
        "id": "faa27509-17b8-37a5-944f-59845a6bac15",
        "contentType": "STORY",
        "title": "What Analysts Think Is Reframing Zimmer Biomet (ZBH) Story For Investors",
        "description": "",
        "summary": "Zimmer Biomet Holdings is back in focus after a recent reset in its price target, putting fresh attention on how investors are framing the stock right now. With the new target reflecting updated expectations and risks, the story around the company is shifting in ways that matter for anyone tracking the shares. Stay tuned to see how you can keep on top of future changes in this narrative as they unfold. Analyst Price Targets don't always capture the full story. Head over to our Company Report...",
        "pubDate": "2026-01-27T12:09:30Z",
        "displayTime": "2026-01-27T12:09:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qYSQ6AG4c18KIEG8bfQS1g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mH32bjf22B8VXoaGCZudBg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/analysts-think-reframing-zimmer-biomet-120930227.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/analysts-think-reframing-zimmer-biomet-120930227.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZBH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]